English
中文
HOME
ABOUT US
COMPANY PROFILE
ENTERPRISE VISION
JOIN US
PRODUCTS
API
ADVANCED INTERMEDIATES
PEPTIDES
FINE CHEMICALS
OTHERS
SERVICE
DMF/CMC/ SMF PREPARATION
PRE-AUDIT/AUDIT INTERPRETATION
PHARMACEUTICAL DOCUMENT TRANSLATION
eCTD DMF SUBMISSION
MOST RECOMMENDED
QUALITY & COMPLIANCE
NEWS
COMPANY NEWS
INDUSTRY NEWS
SENOVA STATEMENT!!!
CONTACT US
Home >
NEWS
NEWS
COMPANY NEWS
INDUSTRY NEWS
SENOVA STATEMENT!!!
Protecting Clinical Trials in Wake of COVID-19
In an unprecedented time of worldwide disruption, Yourway helps you navigate the critical supply chain journey for successful clinical trial development, execution, and conclusion.In this ongoing global pandemic, which has leveled economies and curtailed resea..
2020-04-30
FDA warns that hyped COVID-19 drug hydroxychloroquine is too risky outside the hospital
After President Donald Trump touted the hydroxychloroquine as a potential COVID-19 “game-changer” and the FDA issued an emergency use authorization, the drug regulator is now warning about serious side effects from treatment with the medicine.In a new safety..
2020-04-27
Coronavirus tracker: Novartis trial tackles the chloroquine question; NIH, Gilead post new remdesivir animal results
NIH and Gilead researchers published animal study results showing early remdesivir antiviral treatment helped reduce COVID-19 symptoms and lung damage in rhesus macaques. Meanwhile, one member of Congress is calling on the SEC to investigate last week’s leak ..
2020-04-21
Bayer version of COVID-19 antimalarial hopeful may come with quality concerns: report
Bayer has donated about 3 million doses of its version of the generic antimalarial, marketed as Resochin, sourced from plants in India and in Karachi, Pakistan. Unlike other versions of hydroxychloroquine that have FDA approvals, Bayer's version has no..
2020-04-20
India, hoping to challenge Chinese dominance, plans API production push: report
The novel coronavirus pandemic has caused a host of problems in the global pharmaceutical supply chain—particularly in China, a major producer of drug ingredients. Now, seeing an opportunity, India is reportedly working on a plan to supersize its own ingredie..
2020-04-17
China's CanSino Bio advances COVID-19 vaccine into phase 2 on preliminary safety data
In the global race to develop an effective vaccine to protect people against the novel coronavirus, China’s CanSino Bio has leapt ahead.CanSino and its collaborators at the Academy of Military Medical Sciences’ Institute of Biotechnology plan to move their a..
2020-04-13
First
Previous
current 3/6 page
total 36 records
per page 6 Article
1
2
3
4
5
Next
End
PRODUCTS
API
ADVANCED INTERMEDIATES
PEPTIDES
FINE CHEMICALS
OTHERS
SERVICE
DMF/CMC/ SMF PREPARATION
PRE-AUDIT/AUDIT INTERPRETATION
PHARMACEUTICAL DOCUMENT TRANSLATION
eCTD DMF SUBMISSION
NEWS
COMPANY NEWS
INDUSTRY NEWS
SENOVA STATEMENT!!!
Copyright Copyright (C) 2015-2035 Senova Technology Co. Ltd.
Address: Room2012, Tower A of Shangmei International Building, 1355# Liuxian Avenue, Nanshan Dist., Shenzhen, China 518055 Tel:
+86-0755-8670 3119
QQ: 530953397 Email:
info@senovatech.com